Animal Clinical Investigation
- Company typePrivate
- Founded2000
- HeadquartersChevy Chase, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
Animal Clinical Investigation firmographics
Firmographics- Name
- Animal Clinical Investigation
- Website
- https://animalci.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Animal Clinical Investigation industry classification
Industry- Product category
- Veterinary Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Clinical Research, Trials & Translational Services (Veterinary Regenerative) (HLAMANAL)
Keywords
Where Animal Clinical Investigation is headquartered
LocationHeadquarters
- HQ city
- Chevy Chase
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Animal Clinical Investigation business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Product Development Services: Customized product development services for pharmaceuticals and biologicals for veterinary medicine, including research and development, CMC solutions, and translational medicine support.
- Clinical Study Participation: Open clinical studies inviting pet owners to participate through their veterinarians, generating data for novel therapeutic and prevention options in veterinary medicine.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Animal Clinical Investigation product offering
Product offeringCore offering
Animal Clinical Investigation (ACI Biosciences) delivers customized veterinary clinical research and product development services for pharmaceutical and biological clients, including Research & Development, Chemistry Manufacturing and Controls (CMC) Solutions, and Translational Medicine support from concept to treatment. The company also runs Open Studies that enroll pet patients through veterinary practices to generate data on novel veterinary therapeutics and preventives.
Product overview
ACI Biosciences offers a unified suite of veterinary clinical research and product development services. The core portfolio includes Research & Development for pharmaceuticals and biologicals, CMC Solutions for chemistry, manufacturing and controls, Translational Medicine for cross-species research translation, and Open Studies for clinical trial participation. The company leverages an established network of clinical investigators and subject matter experts to deliver comprehensive product development support from concept to treatment.
Differentiator
Problem solved
Functional benefit
Products and services
- Research & Development Customized product development services for veterinary pharmaceuticals and biologicals, offering access to veterinary specialists and subject matter experts through ACI's established investigator network for clients developing animal health products.
- CMC Solutions Chemistry, Manufacturing and Controls (CMC) solutions providing integrated pharmaceutical development support from concept to treatment, delivered by a team of highly experienced professionals for veterinary pharmaceutical clients.
- Translational Medicine Translational medicine services focused on translating the safety and effectiveness of novel products between species, defining and optimizing research value to advance quality of life for animals and humans, for veterinary pharmaceutical clients.
- Open Studies Open clinical studies that invite pet owners to participate in innovative veterinary trials through engagement with their veterinarians, generating data for novel therapeutic and prevention options in veterinary medicine.
Companies that use Animal Clinical Investigation
Customer profileSegments3 records
Ideal customer profiles1 record
Animal Clinical Investigation technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Animal Clinical Investigation partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- ACI BrasilcoreACI Brasil has launched as a regional expansion of ACI Biosciences, operating as a separate entity (aci-br.com) to serve the Brazilian market for animal health clinical investigation services.
Scale indicators2 records
Recent moves4 records
Expansion highlights4 records
Animal Clinical Investigation competitors and assessment
Company assessmentBroad incumbents
- Elanco Animal Health: Elanco is a global animal health leader with companion animal and livestock pharmaceutical portfolios requiring veterinary clinical investigation and CMC support. Comparable to ACI as a broad incumbent that represents a natural sponsor (or internal competitor) for veterinary CRO services and translational research.
- WuXi AppTec: WuXi AppTec is a leading global CRO/CDMO offering discovery, preclinical, CMC, and clinical development services. Comparable to ACI as a broad incumbent offering end-to-end product development for pharmaceutical and biological sponsors, including veterinary applicants, though at a much larger scale.
- Syngene International: Syngene International is an integrated CRO/CDMO serving global pharmaceutical R&D outsourcing needs across discovery, development, and manufacturing. Comparable to ACI as a broad incumbent offering similar customized R&D and CMC-style services to pharma sponsors and increasingly pursuing animal health and veterinary pharma.
- Charles River Laboratories: Charles River is the largest US-headquartered CRO with established Biomedical Services, Discovery, and Safety Assessment segments that include preclinical veterinary and animal-model research. It is comparable to ACI as a broad incumbent offering veterinary-adjacent CRO services under a wider portfolio, with substantially greater scale and global footprint.
- Labcorp Drug Development (Covance): Labcorp Drug Development (formerly Covance) is a top-3 global CRO with discovery, preclinical, clinical, and central laboratory services. Comparable to ACI as a broad incumbent that has historically served both human and animal health sponsors with full-service product development support across the same translational and CMC workflow.
- Eurofins Scientific: Eurofins is a global testing, contract research, and product development conglomerate with strong pharmaceutical and animal health service lines. Comparable to ACI as a broad incumbent whose Eurofins Discover and Eurofins Veterinary divisions compete for CMC, product development, and clinical research budgets from the same animal health sponsor buyers.
- IQVIA: IQVIA is the world's largest clinical CRO with technology-led development, real-world evidence, and laboratory services. Comparable to ACI as a broad incumbent competing for animal health pharmaceutical and biological sponsor budgets where IQVIA's R&D Solutions group takes on translational and clinical work that overlaps ACI's positioning.
- IDEXX Laboratories: IDEXX is the leading global veterinary diagnostics and reference laboratory company, which also runs commercial veterinary clinical research programs through its reference lab and in-clinic analyzers. Comparable to ACI as a broad incumbent providing data-generation services to veterinary drug developers, though positioned downstream in the development lifecycle.
- Zoetis: Zoetis is the world's largest pure-play animal health company with R&D, manufacturing, and clinical development functions across therapeutics, vaccines, and diagnostics. Comparable to ACI as a broad incumbent that itself engages (and could one day acquire or bypass) specialty veterinary clinical research providers in its own development pipeline.
Direct peers
- Inotiv: Inotiv is a US contract research organization that runs preclinical and translational research programs using animal models and laboratory services. Comparable to ACI because both monetize veterinary and preclinical scientific expertise for pharma and academic sponsors through studies and services that turn animal research into regulatory-grade data.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Animal Clinical Investigation financial estimates
Financial estimateRevenue estimate
Valuation estimate
Animal Clinical Investigation leadership team
Management profileNumber of profiles
Animal Clinical Investigation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Animal Clinical Investigation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Animal Clinical Investigation
What does Animal Clinical Investigation do?
Animal Clinical Investigation (ACI Biosciences) delivers customized veterinary clinical research and product development services for pharmaceutical and biological clients, including Research & Development, Chemistry Manufacturing and Controls (CMC) Solutions, and Translational Medicine support from concept to treatment. The company also runs Open Studies that enroll pet patients through veterinary practices to generate data on novel veterinary therapeutics and preventives.
Is Animal Clinical Investigation a public or private company?
Animal Clinical Investigation is a private company. It is classified as unknown and is currently operating.
When was Animal Clinical Investigation founded?
Animal Clinical Investigation was founded in 2000. It employs 11 to 50 people.
Where is Animal Clinical Investigation based?
Animal Clinical Investigation is headquartered in Chevy Chase, United States, in the North America region.
How does Animal Clinical Investigation make money?
Two revenue lines are on record. Product Development Services are the primary driver. The others are clinical Study Participation.
Who are Animal Clinical Investigation's main competitors?
Broad incumbents on record are Elanco Animal Health, WuXi AppTec, Syngene International, Charles River Laboratories, Labcorp Drug Development (Covance), Eurofins Scientific, IQVIA, IDEXX Laboratories and Zoetis. Inotiv is listed as a direct peer.
Does Animal Clinical Investigation have an API?
No public API is recorded for Animal Clinical Investigation.
What industry is Animal Clinical Investigation in?
Animal Clinical Investigation's product category is Veterinary Clinical Research Services. Its primary akta.pro industry code is HLAMANAL, Clinical Research, Trials & Translational Services (Veterinary Regenerative). Its NAICS code is 5417 and its SIC code is 8731.